No sooner do I say I will not do this often than two stories leap off the page at me. This article is much more technical, but reports on a trial of a method for slowing down NEC after it has metastasized to the liver–which is where Jane was when she was diagnosed.

This feels to me to be a very positive development. I hope those of you in the medical field will let me know if this is as promising as it looks in the PR piece.

Here is the link: http://www.marketwatch.com/story/positive-phase-2-trial-results-from-neuroendocrine-tumor-cohort-presented-at-cirse-2011-09-12

I will post both these stories to the Resources page as well as posting them here.